Chronic Open Angle Glaucoma (COAG)

NICE guideline [NG81] Glaucoma: diagnosis and management. Last updated Jan 2022. This article only covers open angle glaucoma and ocular hypertension. Angle closure glaucoma is covered in a separate article.

Background Information

Term Definition Notes
Ocular hypertension Raised IOP (>21 mmHg) WITHOUT optic nerve damage / visual field loss At risk of developing glaucoma
Glaucoma Chronic optic nerve neuropathy characterised by optic disc cupping and visual-field defects

NOT always associated with ocular hypertension
Umbrella term that includes:
  • Normal tension glaucoma
  • Chronic open angle glaucoma
  • Angle-closure glaucoma
  • Secondary glaucoma
Normal tension glaucoma Chronic optic nerve neuropathy with NORMAL IOP Thought to involve vascular or structural susceptibility rather than IOP alone
Chronic open-angle glaucoma Characterised by:
  • Open anterior chamber angle
  • Gradual IOP rise
  • Progressive optic nerve neuropathy
The most common form of glaucoma

Most cases present chronically
Angle-closure glaucoma Characterised by raised IOP secondary to a closed anterior chamber angle Most cases present acutely
 

Raised IOP ≠ glaucoma. Optic nerve neuropathy is needed for it to be glaucoma, indicated by optic disc cupping and visual-field defects.

Guidelines

 Offer ALL the following tests before referral:
  • Central visual field assessment using automated perimetry
  • IOP measurement with Golmann-type applanation tonometry
  • Optic nerve assessment and fundus examination with stereoscopic slit lamp biomicroscopy and OCT or optic nerve head image 
  • Peripheral anterior chamber configuration and depth assessment with gonioscopy / van Herick test / OCT

After the above tests, refer if ANY of the following:
  • IOP ≥24 mmHg (measured with Goldmann-type applanation tonometry)
  • Visual field defect
  • Optic nerve head damage 

Offer ALL the following tests to diagnose COAG:
  • Central visual field assessment using automated perimetry
  • IOP measurement with Golmann-type applanation tonometry (slit lamp mounted)
  • Optic nerve assessment and fundus examination with stereoscopic slit lamp biomicroscopy with pupil dilatation
  • Peripheral anterior chamber configuration and depth assessment with gonioscopy
  • Central corneal thickness measurement
    • A thin cornea underestimates true IOP and tick cornea overestimates IOP

Indications to treat: IOP ≥24 mmHg + at risk of visual impairment within their lifetime
 

  • 1st line: 360° selective laser trabeculoplasty (SLT)
    • Consider a second attempt if the initial successful SLT has reduced over time
 
  • 2nd line: generic prostaglandin analogue eye drops
 
  • 3rd line: beta blocker eye drops
 
  • 4th line: beta blocker / carbonic anhydrase inhibitor / sympathomimetic eye drops
 
 

360° SLT can delay the need for eye drops and can reduce but does not remove the chance will be needed at all.

Indications to treat: IOP ≥24 mmHg OR at risk of visual impairment within their lifetime
 

  • 1st line: 360° selective laser trabeculoplasty (SLT)
    • Consider a second attempt if the initial successful SLT has reduced over time
 
  • 2nd line: generic prostaglandin analogue eye drops
  • 3rd line: beta blocker / carbonic anhydrase inhibitor / sympathomimetic eye drops OR glaucoma surgery with mitomycin-C
 
  • 4th line: cyclodiode laser treatment

360° SLT can delay the need for eye drops and can reduce but does not remove the chance will be needed at all.

  • Glaucoma surgery, AND

  • Pharmacological augmentation with mitomycin-C

At each assessment, offer the Goldmann applanation tonometry (slit lamp mounted)

If clinically indicated, also offer:
  • Anterior segment slit lamp examination with van Herick peripheral anterior chamber depth assessment
  • Repeat gonioscopy
  • Repeat visual field testing with automated perimetry
  • Repeat assessment of the optic nerve head

References

Author: Adams Lau
Reviewer:
Last edited: 08/05/25